**Summary**
Tristel plc, a global infection prevention company listed on the London Stock Exchanges AIM market (AIM: TSTL), has announced the release date for its interim results for the six-month period ending December 31, 2025. The results will be published on **Monday, March 2, 2026**.
Key events surrounding the announcement include
1. **Analyst Briefing**A London-based briefing for analysts will take place on March 2, 2026, at 11:00 AM. Registration details are available via Walbrook PR.
2. **Investor Presentations**Two presentations will be held on the same day
An online presentation via the Investor Meet Company platform at 9:30 AM, open to all existing and potential shareholders.
An in-person presentation in the City of London at 4:30 PM, followed by refreshments. Both events will feature CEO Matt Sassone and CFO Anna Wasyl.
Tristel, headquartered near Cambridge, specializes in infection prevention products using proprietary chlorine dioxide (ClO2) chemistry. The company operates globally, targeting double-digit revenue growth, a 25%+ EBITDA margin, and progressive dividend growth.
For further details, investors can contact Walbrook PR or visit Tristelโs investor website. The results presentation will also be available on the companyโs website on the day of the announcement.
Financial and Debt Comparison (Year-on-Year)
| Metric | 2024 | 2025 | Change |
|---|---|---|---|
| Revenue | ยฃX,XXX,XXX | ยฃX,XXX,XXX | X% |
| EBITDA | ยฃX,XXX,XXX | ยฃX,XXX,XXX | X% |
| Net Debt | ยฃX,XXX,XXX | ยฃX,XXX,XXX | X% |